spacer
home > epc > winter 2009 > cro market: annual review
PUBLICATIONS
European Pharmaceutical Contractor

CRO Market: Annual Review

“The good CEO, the one who will remain and stay in charge, is the one who learns how to outsource”, said Philippe Courtot, CEO of Qualys, a company that provides IT risk management solutions to the engineering industry. I have previously noted in several publications that the pharmaceutical industry is relatively new to outsourcing, but recent advances in strategic outsourcing as practiced by Wyeth, Solvay and, most recently, Eli Lilly show the beginnings of real comprehension of what outsourcing is all about.

In 1991, the CEO of Sasson, a $250 million company with just nine employees, said “I have to keep networking everywhere, looking for good partners”. The pharmaceutical industry is still miles away from being as lean as Sasson, but outsourcing is certainly on an upward path.

In his book Liberation Management, Tom Peters quotes Groucho Marx, “I wouldn’t want to join any club that would have me as a member” and suggests a variation: “I would not want to work with a subcontractor who would have me as a partner”. This is a way of saying that you should only work with CROs who you believe are better than you. This may be anathema to company-proud CRO managers in pharmaceutical companies, but the current economic conditions may force them to change their minds. CROs are essential to the pharmaceutical industry and it behoves the industry, therefore, to support, nurture, train, encourage and improve the sector.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Graham Hughes is a leading expert in the field of outsourcing in Pharmaceutical Development. He was the founder and Scientific Director of Technomark Consulting Services in 1987. Graham is Editor of European Pharmaceutical Contractor and International Clinical Trials. He is a frequent speaker and chairman at national and international conferences on outsourcing and drug development. He has also run numerous workshops on the selection and management of CROs. He has recently been Chairman of Auxetica, a UK-based medical device company, and is President of Aginko AG, a Swiss CRO specialising in musculo-skeletal medicine. He is currently a Director of Oxford Cardiac Pharmacology Ltd and Vice President of Technomark Life Sciences, which is based in the US.

spacer
Graham Hughes
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

WuXi STA and Dizal Pharmaceutical Sign CMC Development and Manufacturing Agreement

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Dizal Pharmaceutical, a biotechnology company, announce a strategic partnership. Under the terms of the collaboration, WuXi STA will become the preferred CDMO partner of Dizal Pharmaceutical for GMP production, providing integrated CMC (Chemical, manufacturing and Control) process research and manufacturing services from API to drug product.
More info >>

White Papers

Working Towards a Standardised Identification Solution

PCI Pharma Services

The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement